These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2891647

  • 1. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
    Franc B, Chayvialle JA, Modigliani E, Calmettes C, Caillou B, Dutrieux-Berger N, Houdent C, Kujas M.
    Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
    [No Abstract] [Full Text] [Related]

  • 2. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N, Ahuja S, Diel F.
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [Abstract] [Full Text] [Related]

  • 3. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE, VanVickle J, Froome LC, Mendelsohn G, Baylin SB, Wells SA.
    Surg Forum; 1979 Dec; 30():120-1. PubMed ID: 395674
    [No Abstract] [Full Text] [Related]

  • 4. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
    Saito H, Saito S.
    Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
    [Abstract] [Full Text] [Related]

  • 5. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
    Modigliani E, Casanova S, Chayvialle JA, Bernard C, Franc B, Cohen R, Calmettes C.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
    Sundler F, Alumets J, Håkanson R, Björklund L, Ljungberg O.
    Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
    [Abstract] [Full Text] [Related]

  • 7. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B, Vagneur JP, Conforto C, Even F, Rollat MC, Simonin R.
    Bull Cancer; 1984 Aug; 71(2):133-9. PubMed ID: 6733293
    [Abstract] [Full Text] [Related]

  • 8. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M, Välimäki M, Pelkonen R, Jansson R, Sivula A, Franssila K.
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
    Henninger S, Schatz H, Stracke H, Wagner U, Kracht J.
    Acta Histochem; 1988 Nov; 83(1):51-6. PubMed ID: 2897752
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A, Onishi T, Matsuzuka F, Hirai K, Kuma K, Takai S, Nakamoto K, Nakamura K, Nanjo S, Maeda M.
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [Abstract] [Full Text] [Related]

  • 11. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C, Moudktar MS, Milhaud G.
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [Abstract] [Full Text] [Related]

  • 12. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma.
    Cote GJ, Gagel RF.
    Henry Ford Hosp Med J; 1987 Mar; 35(2-3):149-52. PubMed ID: 2891648
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of synthesis of carcinoembryonic antigen and calcitonin in patients with medullary carcinoma of the thyroid (author's transl)].
    Ishikawa N.
    Kaku Igaku; 1979 Feb; 16(1):29-35. PubMed ID: 439489
    [No Abstract] [Full Text] [Related]

  • 14. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C, Argemi B, Cannoni M, Oliver C, Gillioz P, Vagneur JP, Toga M.
    Ann Pathol; 1984 Feb; 4(1):27-35. PubMed ID: 6142718
    [Abstract] [Full Text] [Related]

  • 15. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
    Elsner B, De Marco L, López S, Curutchet HP.
    Medicina (B Aires); 1983 Feb; 43(3):263-70. PubMed ID: 6369069
    [No Abstract] [Full Text] [Related]

  • 16. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
    Epstein S, Berelowitz M, Bell NH.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1227-31. PubMed ID: 6108330
    [Abstract] [Full Text] [Related]

  • 17. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J, Oehr P, Grouls V.
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract] [Full Text] [Related]

  • 18. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S, Lazzara S, Palmeri R, Belnome N, Calbo L, Dattola P, Melita P.
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [Abstract] [Full Text] [Related]

  • 19. Plasma somatostatin activity in medullary cancer of the thyroid.
    Neradilová M, Nĕmec J, Zamrazil V, Bednár J, Pechová M, Soutorová M.
    Oncology; 1989 Feb; 46(6):378-80. PubMed ID: 2573874
    [Abstract] [Full Text] [Related]

  • 20. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
    Birnbaum RS, Muszynski M, Roos BA.
    Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.